Copy number variations in the survival motor neuron genes: Implications for spinal muscular atrophy and other neurodegenerative diseases

Frontiers in Molecular Biosciences

Volumn 3, Issue MAR, 2016, Pages

  Butchbach, Matthew E R ^a,b,c  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Copy number variation; Neurodegenerative disease; Progressive muscular atrophy; SMN1; SMN2; Spinal muscular atrophy

Indexed keywords

EID: 85002959925     PISSN: None     EISSN: 2296889X     Source Type: Journal    
DOI: 10.3389/fmolb.2016.00007     Document Type: Review

References (158)

1. Alías, L., Bernal, S., Barceló, M. J., Also-Rallo, E., Martínez-Hernández, R., Rodríguez-Alvarez, F. J., et al. (2011). Accuracy of marker analysis, quantitative real-time polymerase chain reaction and multiple ligation-dependent probe amplification to determine SMN2 copy number in patients with spinal muscular atrophy. Genet. Test. Mol. Biomarkers 15, 587-594. doi: 10.1089/gtmb.2010.0253
2. Amara, A., Adala, L., Ben Charfeddine, I., Mamaï, O., Mili, A., Ben Lazreg, T., et al. (2012). Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients. Eur. J. Paediatr. Neurol. 16, 167-174. doi: 10.1016/j.ejpn.2011.07.007
3. Anhuf, D., Eggermann, T., Rudnik-Schöneborn, S., and Zerres, K. (2003). Determination of SMN1 and SMN2 copy number using TaqMan technology. Hum. Mutat. 22, 74-78. doi: 10.1002/humu.10221
4. Appelbaum, J. S., Roos, R. P., Salazar-Grueso, E. F., Buchman, A., Iannaccone, S., Glantz, R., et al. (1992). Intrafamilial heterogeneity in hereditary motor neuron disease. Neurology 42, 1488-1492. doi: 10.1212/WNL.42.8.1488
5. Arkblad, E. L., Darin, N., Berg, K., Kimber, E., Brandberg, G., Lindberg, C., et al. (2006). Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy. Neuromuscul. Disord. 16, 830-838. doi: 10.1016/j.nmd.2006.08.011
6. Arnold, W. D., and Burghes, A. H. M. (2013). Spinal muscular atrophy: development and implementation of potential therapeutics. Ann. Neurol. 74, 348-362. doi: 10.1002/ana.23995
7. Ben-Shachar, S., Orr-Urtreger, A., Bardugo, E., Shomrat, R., and Yaron, Y. (2011). Large-scale population screening for spinal muscular atrophy: clinical implications. Genet. Med. 13, 110-114. doi: 10.1097/GIM.0b013e3182017c05
8. Bernal, S., Alías, L., Barceló, M. J., Also-Rallo, E., Martínez-Hernández, R., Gámez, J., et al. (2010). The c.859G>C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor. J. Med. Genet. 47, 640-642. doi: 10.1136/jmg.2010.079004
9. Bernal, S., Also-Rallo, E., Martínez-Hernández, R., Alías, L., Rodríguez-Alvarez, F. J., Millán, J. M., et al. (2011). Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings. Neuromuscul. Disord. 21, 413-419. doi: 10.1016/j.nmd.2011.03.009
10. Blauw, H. M., Barnes, C. P., van Vught, P. W. J., van Rheenen, W., Verheul, M., Cuppen, E., et al. (2012). SMN1 gene duplications are associated with sporadic ALS. Neurology 78, 776-780. doi: 10.1212/WNL.0b013e318249f697
11. Boylan, K. (2015). Familial amyotrophic lateral sclerosis. Neurol. Clin. 33, 807-830. doi: 10.1016/j.ncl.2015.07.001
12. Brandt, S. (1949). Hereditary factors in infantile progressive muscular atrophy; study of 112 cases in 70 families. Am. J. Dis. Child. 78, 226-236. doi: 10.1001/archpedi.1949.02030050237007
13. Brkušanin, M., Kosac, A., Jovanovic, V., Pešovic, J., Brajuškovic, G., Dimitrijevic, N., et al. (2015). Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients. J. Hum. Genet. 60, 723-728. doi: 10.1038/jhg.2015.104
14. Brzustowicz, L. M., Lehner, T., Castilla, L. H., Penchaszadeh, G. K., Wilhelmsen, K. C., Daniels, R., et al. (1990). Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 344, 540-541. doi: 10.1038/344540a0
15. Burghes, A. H. M., and Beattie, C. E. (2009). Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci. 10, 597-609. doi: 10.1038/nrn2670
16. Burghes, A. H. M., Ingraham, S. E., Kóte-Jarai, Z., Rosenfeld, S., Herta, N., Nadkarni, N., et al. (1994). Linkage mapping of the spinal muscular atrophy gene. Hum. Genet. 93, 305-312. doi: 10.1007/BF00212028
17. Burghes, A. H. M. (1997). When is a deletion not a deletion? When it is converted. Am. J. Hum. Genet. 61, 9-15. doi: 10.1086/513913
18. Bürglen, L., Seroz, T., Miniou, P., Lefebvre, S., Burlet, P., Munnich, A., et al. (1997). The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease. Am. J. Hum. Genet. 60, 72-79
19. Burlet, P., Bürglen, L., Clermont, O., Lefebvre, S., Viollet, L., Munnich, A., et al. (1996). Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease. J. Med. Genet. 33, 281-283. doi: 10.1136/jmg.33.4.281
20. Burnett, B. G., Muñoz, E., Tandon, A., Kwon, D. Y., Sumner, C. J., and Fischbeck, K. H. (2009). Regulation of SMN protein stability. Mol. Cell. Biol. 29, 1107-1115
21. Butchbach, M. E. R., and Burghes, A. H. M. (2004). Perspectives on models of spinal muscular atrophy for drug discovery. Drug Discover. Today Dis. Models 1, 151-156. doi: 10.1016/j.ddmod.2004.07.001
22. Campbell, L., Potter, A., Ignatius, J., Dubowitz, V., and Davies, K. (1997). Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am. J. Hum. Genet. 61, 40-50. doi: 10.1086/513886
23. Camu, W., and Billiard, M. (1993). Coexistence of amyotrophic lateral sclerosis and Werdnig-Hoffmann disease within a family. Muscle Nerve 16, 569-570
24. Carrel, T. L., McWhorter, M. L., Workman, E., Zhang, H., Wolstencroft, E. C., Lorson, C., et al. (2006). Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 26, 11014-11022. doi: 10.1523/JNEUROSCI.1637-06.2006
25. Carter, T. A., Bönnemann, C. G., Wang, C. H., Obici, S., Parano, E., De Fatima Bonaldo, M., et al. (1997). A multicopy transcription-repair gene, BTF2p44, maps to the SMA region and demonstrates SMA associated deletions. Hum. Mol. Genet. 6, 229-236. doi: 10.1093/hmg/6.2.229
26. Cherry, J. J., Kobayashi, D. T., Lynes, M. M., Naryshkin, N. N., Tiziano, F. D., Zaworksi, P. G., et al. (2014). Assays for the identification and prioritization of drug candidates for spinal muscular atrophy. Assay Drug Dev. Technol. 12, 315-341. doi: 10.1089/adt.2014.587
27. Cho, S., and Dreyfuss, G. (2010). A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev. 24, 438-442. doi: 10.1101/gad.1884910
28. Cifuentes-Diaz, C., Nicole, S., Velasco, M. E., Borra-Cebrian, C., Panozzo, C., Frugier, T., et al. (2002). Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum. Mol. Genet. 11, 1439-1447. doi: 10.1093/hmg/11.12.1439
29. Cobben, J. M., van der Steege, G., Grootscholten, P., de Visser, M., Scheffer, H., and Buys, C. H. (1995). Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am. J. Hum. Genet. 57, 805-808
30. Coovert, D. D., Le, T. T., McAndrew, P. E., Strasswimmer, J., Crawford, T. O., Mendell, J. R., et al. (1997). The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6, 1205-1214. doi: 10.1093/hmg/6.8.1205
31. Corcia, P., Camu, W., Halimi, J. M., Vourc'h, P., Antar, C., Vedrine, S., et al. (2006). SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology 67, 1147-1150. doi: 10.1212/01.wnl.0000233830.85206.1e
32. Corcia, P., Ingre, C., Blasco, H., Press, P., Praline, J., Antar, C., et al. (2012). Homozygous SMN2 deletion is a protective factor in the Swedish ALS population. Eur. J. Hum. Genet. 20, 588-591. doi: 10.1038/ejhg.2011.255
33. Corcia, P., Khoris, J., Couratier, P., Mayeux-Portas, V., Bieth, E., de Toffol, B., et al. (2002a). SMN1 gene study in three families in which ALS and spinal muscular atrophy co-exist. Neurology 59, 1464-1466. doi: 10.1212/01.WNL.0000032500.73621.C5
34. Corcia, P., Mayeux-Portas, V., Khoris, J., de Toffol, B., Autret, A., Müh, J. P., et al. (2002b). Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann. Neurol. 51, 243-246. doi: 10.1002/ana.10104
35. Courseaux, A., Richard, F., Grosgeorge, J., Ortola, C., Viale, A., Turc-Carel, C., et al. (2003). Segmental duplications in euchromatic regions of human chromosome 5: a source of evolutionary instability and transcriptional innovation. Genome Res. 13, 369-381. doi: 10.1101/gr.490303
36. Crawford, T. O., and Pardo, C. A. (1996). The neurobiology of childhood spinal muscular atrophy. Neurobiol. Dis. 3, 97-110. doi: 10.1006/nbdi.1996.0010
37. Crawford, T. O., Paushkin, S. V., Kobayashi, D. T., Forrest, S. J., Joyce, C. L., Finkel, R. S., et al. (2012). Evaluation of SMN protein, transcript and copy number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study. PLoS ONE 7:e33572. doi: 10.1371/journal.pone.0033572
38. Crawford, T. O., and Skolasky, R. L. Jr. (2002). The relationship of SMN to amyotrophic lateral sclerosis. Ann. Neurol. 52, 857-858. doi: 10.1002/ana.10378
39. Cuscó, I., Barceló, M. J., Rojas-García, R., Illa, I., Gámez, J., Cervera, C., et al. (2006). SMN2 copy number predicts acute or chronic spinal muscular atrophy but does not account for intrafamilial variability in siblings. J. Neurol. 253, 21-25. doi: 10.1007/s00415-005-0912-y
40. Cuscó, I., Barceló, M. J., Soler, C., Parra, J., Baiget, M., and Tizzano, E. (2002). Prenatal diagnosis for risk of spinal muscular atrophy. Br. J. Obstet. Gynaecol. 109, 1244-1249. doi: 10.1016/S1470-0328(02)02983-X
41. Devriendt, K., Lammens, M., Schollen, E., Van Hole, C., Dom, R., Devlieger, H., et al. (1996). Clinical and molecular genetic features of congenital spinal muscular atrophy. Ann. Neurol. 40, 731-738. doi: 10.1002/ana.410400509
42. DiDonato, C. J., Chen, X. N., Noya, D., Korenberg, J. R., Nadeau, J. H., and Simard, L. R. (1997a). Cloning, characterization and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. Genome Res. 7, 339-352
43. DiDonato, C. J., Ingraham, S. E., Mendell, J. R., Prior, T. W., Lenard, S., Moxley, R. T., et al. (1997b). Deletion and conversion in spinal muscular atrophy: is there a relationship to severity? Ann. Neurol. 41, 230-237. doi: 10.1002/ana.410410214
44. Dobrowolski, S. F., Pham, H. T., Pouch-Downes, F., Prior, T. W., Naylor, E. W., and Swoboda, K. J. (2012). Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling. Clin. Chem. 58, 1033-1039. doi: 10.1373/clinchem.2012.183038
45. Elsheikh, B., Prior, T., Zhang, X., Miller, R., Kolb, S. J., Moore, D., et al. (2009). An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy. Muscle Nerve 40, 652-656. doi: 10.1002/mus.21350
46. Fang, P., Li, L., Zhou, W. J., Wu, W. Q., Zhong, Z. Y., Yan, T. Z., et al. (2015). Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls. BMC Musculoskelet. Disord. 16:11. doi: 10.1186/s12891-015-0457-x
47. Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., and Wirth, B. (2002). Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am. J. Hum. Genet. 70, 358-368. doi: 10.1086/338627
48. Gabanella, F., Carissimi, C., Usiello, A., and Pellizzoni, L. (2005). The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation. Hum. Mol. Genet. 14, 3629-3642. doi: 10.1093/hmg/ddi390
49. Gamez, J., Barceló, M. J., Muñoz, X., Carmona, F., Cuscó, I., Baiget, M., et al. (2002). Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients. Neurology 59, 1456-1460. doi: 10.1212/01.WNL.0000032496.64510.4E
50. Gérard, B., Ginet, N., Matthijs, G., Evrard, P., Baumann, C., Da Silva, F., et al. (2004). Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension. Hum. Mutat. 16, 253-263. doi: 10.1002/1098-1004(200009)16:3<253::AID-HUMU8>3.0.CO;2-8
51. Gerbino, V., Carrì, M. T., Cozzolino, M., and Achsel, T. (2013). Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm. Neurobiol. Dis. 55, 120-128. doi: 10.1016/j.nbd.2013.03.003
52. Gilliam, T. C., Brzustowicz, L. M., Castilla, L. H., Lehner, T., Penchaszadeh, G. K., Daniels, R. J., et al. (1990). Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 345, 823-825. doi: 10.1038/345823a0
53. Gómez-Curet, I., Robinson, K. G., Funanage, V. L., Crawford, T. O., Scavina, M., and Wang, W. (2007). Robust quantification of the SMN gene copy number by real-time TaqMan PCR. Neurogenetics 8, 271-278. doi: 10.1007/s10048-007-0093-1
54. Groen, E. J. N., Fumoto, K., Blokhuis, A. M., Engelen-Lee, J. Y., Zhou, Y., van den Heuvel, D. M. A., et al. (2013). ALS-associated mutations in FUS disrupt the axonal distribution and localization of SMN. Hum. Mol. Genet. 22, 3690-3704. doi: 10.1093/hmg/ddt222
55. Hahnen, E., Forkert, R., Marke, C., Rudnik-Schöneborn, S., Schonling, J., Zerres, K., et al. (1995). Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum. Mol. Genet. 4, 1927-1933. doi: 10.1093/hmg/4.10.1927
56. Hahnen, E., Schönling, J., Rudnik-Schöneborn, S., Zerres, K., and Wirth, B. (1996). Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: new insights into molecular mechanisms responsible for the disease. Am. J. Hum. Genet. 59, 1057-1065
57. Hendrickson, B. C., Donohoe, C., Akmaev, V. R., Sugarman, E. A., Labrousse, P., Boguslavskiy, L., et al. (2009). Differences in SMN1 allele frequencies among ethnic groups within North America. J. Med. Genet. 46, 641-644. doi: 10.1136/jmg.2009.066969
58. Hsieh-Li, H. M., Chang, J. G., Jong, Y. J., Wu, M. H., Wang, N. M., Tsai, C. H., et al. (2000). A mouse model for spinal muscular atrophy. Nat. Genet. 24, 66-70. doi: 10.1038/71709
59. Huang, C. H., Chang, Y. Y., Chen, C. H., Kuo, Y. S., Hwu, W. L., Gerdes, T., et al. (2007). Copy number analysis of survival motor neuron genes by multiplex ligation-dependent probe amplification. Genet. Med. 9, 241-248. doi: 10.1097/GIM.0b013e31803d35bc
60. Ishihara, T., Ariizumi, Y., Shiga, A., Kato, T., Tan, C. F., Sato, T., et al. (2013). Decreased number of gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 4136-4147. doi: 10.1093/hmg/ddt262
61. Jackson, M., Morrison, K. E., Al-Chalabi, A., Bakker, M., and Leigh, P. N. (1996). Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: homozygous NAIP deletion in a sporadic case. Ann. Neurol. 39, 796-800. doi: 10.1002/ana.410390616
62. Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Vande Velde, C., et al. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574. doi: 10.1038/ng.132
63. Kariya, S., Re, D. B., Jacquier, A., Nelson, K., Przedborski, S., and Monani, U. R. (2012). Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies. Hum. Mol. Genet. 21, 3421-3434. doi: 10.1093/hmg/dds174
64. Kariya, S., Sampson, J. B., Northrop, L. E., Luccarelli, C. M., Naini, A. B., Re, D. B., et al. (2014). Nuclear localization of SMN and FUS is not altered in fibroblasts from patients with sporadic ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 15, 581-587. doi: 10.3109/21678421.2014.907319
65. Kim, J., Lee, S. G., Choi, Y. C., Kang, S. W., Lee, J. B., Choi, J. R., et al. (2010). Association betwen survivor motor neuron 2 (SMN2) gene homozygous deletion and sporadic lower motor neuron disease in a Korean population. Ann. Clin. Lab. Sci. 40, 368-374
66. Kirwin, S. M., Vinette, K. M. B., Gonzalez, I. L., Al Abdulwahed, H., Al-Sannaa, N., and Funanage, V. L. (2013). A homozygous double mutation in SMN1: a complicated genetic diagnosis of SMA. Mol. Genet. Genomic Med. 1, 113-117. doi: 10.1002/mgg3.10
67. Kolb, S. J., Gubitz, A. K., Olszewski, R. F. Jr., Ottinger, E., Sumner, C. J., Fischbeck, K. H., et al. (2006). A novel cell immunoassay to measure survival of motor neurons protein in blood cells. BMC Neurol. 6:6. doi: 10.1186/1471-2377-6-6
68. Kolb, S. J., and Kissel, J. T. (2015). Spinal muscular atrophy. Neurol. Clin. 33, 831-846. doi: 10.1016/j.ncl.2015.07.004
69. Kuzma-Kozakiewicz, M., Jedrzejowska, M., and Kazmierczak, B. (2013). SMN1 gene duplications are more frequent in patients with progressive muscular atrophy. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 457-462. doi: 10.3109/21678421.2013.771367
70. Kwiatkowski, T. J Jr., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vandenburg, C. R., Russ, C., et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208. doi: 10.1126/science.1166066
71. Labrum, R., Rodda, J., and Krause, A. (2007). The molecular basis of spinal muscular atrophy (SMA) in South African black patients. Neuromuscul. Disord. 17, 684-692. doi: 10.1016/j.nmd.2007.05.005
72. Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., et al. (2005). SMND7, the major product of the centromeric survival motor neuron gene (SMN2), extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet. 14, 845-857. doi: 10.1093/hmg/ddi078
73. Lee, J. B., Lee, K. A., Hong, J. M., Suh, G. I., and Choi, Y. C. (2012). Homozygous SMN2 deletion is a major risk factor among twenty-five Korean sporadic amyotrophic lateral sclerosis patients. Yonsei Med. J. 53, 53-57. doi: 10.3349/ymj.2012.53.1.53
74. Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., et al. (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165. doi: 10.1016/0092-8674(95)90460-3
75. Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., et al. (1997). Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 16, 265-269. doi: 10.1038/ng0797-265
76. Liewluck, T., and Saperstein, D. S. (2015). Progressive muscular atrophy. Neurol. Clin. 33, 761-773. doi: 10.1016/j.ncl.2015.07.005
77. Liu, Q., and Dreyfuss, G. (1996). A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 15, 3555-3565
78. Lorson, C. L., and Androphy, E. J. (2000). An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet. 9, 259-265. doi: 10.1093/hmg/9.2.259
79. Lorson, C. L., Hahnen, E., Androphy, E. J., and Wirth, B. (1999). A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. U.S.A. 96, 6307-6311. doi: 10.1073/pnas.96.11.6307
80. Lyahyai, J., Sbiti, A., Barkat, A., Ratbi, I., and Sefiani, A. (2012). Spinal muscular atrophy carrier frequency and estimated prevalence of the disease in Moroccan newborns. Genet. Test. Mol. Biomarkers 16, 215-218. doi: 10.1089/gtmb.2011.0149
81. Mailman, M. D., Heinz, J. W., Papp, A. C., Snyder, P. J., Sedra, M. S., Wirth, B., et al. (2002). Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet. Med. 4, 20-26. doi: 10.1097/00125817-200201000-00004
82. McAndrew, P. E., Parsons, D. W., Simard, L. R., Rochette, C., Ray, P. N., Mendell, J. R., et al. (1997). Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am. J. Hum. Genet. 60, 1411-1422. doi: 10.1086/515465
83. McWhorter, M. L., Monani, U. R., Burghes, A. H. M., and Beattie, C. E. (2003). Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919-931. doi: 10.1083/jcb.200303168
84. Melki, J., Abdelhak, S., Sheth, P., Bachelot, M. F., Burlet, P., Marcadet, A., et al. (1990a). Genes for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 344, 767-768. doi: 10.1038/344767a0
85. Melki, J., Sheth, P., Abdelhak, S., Burlet, P., Bachelot, M. F., Lathrop, M. G., et al. (1990b). Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators. Lancet 336, 271-273. doi: 10.1016/0140-6736(90)91803-I
86. Michaud, M., Arnoux, T., Bielli, S., Durand, E., Rotrou, Y., Jablonka, S., et al. (2010). Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiol. Dis. 38, 125-135. doi: 10.1016/j.nbd.2010.01.006
87. Monani, U. R., Lorson, C. L., Parsons, D. W., Prior, T. W., Androphy, E. J., Burghes, A. H. M., et al. (1999). A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8, 1177-1183. doi: 10.1093/hmg/8.7.1177
88. Monani, U. R., Sendtner, M., Coovert, D. D., Parsons, D. W., Andreassi, C., Le, T. T., et al. (2000). The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/-mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333-339. doi: 10.1093/hmg/9.3.333
89. Morrison, K. E. (1996). Advances in SMA research: review of gene deletions. Neuromuscul. Disord. 6, 397-408. doi: 10.1016/S0960-8966(96)00368-9
90. Moulard, B., Salachas, F., Chassande, B., Briolotti, V., Meininger, V., Malafosse, A., et al. (1998). Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann. Neurol. 43, 640-644. doi: 10.1002/ana.410430513
91. Munsat, T. L., and Davies, K. E. (1992). International SMA Consortium meeting. Neuromuscul. Disord. 2, 423-428. doi: 10.1016/S0960-8966(06)80015-5
92. Nicole, S., Desforges, B., Millet, G., Lesbordes, J., Cifuentes-Diaz, C., Vertes, D., et al. (2003). Intact satellite cells lead to remarkable protection against Smn gene defect in differentiation skeletal muscle. J. Cell Biol. 161, 571-582. doi: 10.1083/jcb.200210117
93. Oprea, G. E., Kröber, S., McWhorter, M. L., Rossoll, W., Müller, S., Krawczak, M., et al. (2008). Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320, 524-527. doi: 10.1126/science.1155085
94. Orrell, R. W., Habgood, J. J., de Belleroche, J. S., and Lane, R. J. M. (1997). The relationship of spinal muscular atrophy to motor neuron disease. Investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J. Neurol. Sci. 145, 55-61. doi: 10.1016/S0022-510X(96)00240-7
95. Parboosingh, J. S., Meininger, V., McKenna-Yasek, D., Brown, R. H. Jr., and Rouleau, G. A. (1999). Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch. Neurol. 56, 710-712. doi: 10.1001/archneur.56.6.710
96. Pearn, J. (1978). Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy. J. Med. Genet. 15, 409-413. doi: 10.1136/jmg.15.6.409
97. Pellizzoni, L. (2007). Chaperoning ribonucleoprotein biogenesis in health and disease. EMBO Rep. 8, 340-345. doi: 10.1038/sj.embor.7400941
98. Prior, T. W., Krainer, A. R., Hua, Y., Swoboda, K. J., Snyder, P. C., Bridgeman, S. J., et al. (2009). A positive modifier of spinal muscular atrophy in the SMN2 gene. Am. J. Hum. Genet. 85, 408-413. doi: 10.1016/j.ajhg.2009.08.002
99. Prior, T. W., Nagan, N., Sugarman, E. A., Batish, S. D., and Braastad, C. (2011). Technical standards and guidelines for spinal muscular atrophy testing. Genet. Med. 13, 686-694. doi: 10.1097/GIM.0b013e318220d523
100. Prior, T. W., Swoboda, K. J., Scott, H. D., and Hejmanowski, A. Q. (2005). Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am. J. Med. Genet. 130A, 307-310. doi: 10.1002/ajmg.a.30251
101. Qu, Y., Ge, X., Bai, J., Wang, L., Cao, Y., Lu, Y., et al. (2014). Association of copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein gene with the natural history in a Chinese spinal muscular atrophy cohort. J. Child Neurol. 30, 429-436. doi: 10.1177/0883073814553271
102. Renton, A. E., Chiò, A., and Traynor, B. J. (2014). State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17-23. doi: 10.1038/nn.3584
103. Rochette, C. F., Gilbert, N., and Simard, L. R. (2001). SMN gene duplication and emergence of the SMN2 gene occured in distinct hominids: SMN2 is unique to Homo sapiens. Hum. Genet. 108, 255-266. doi: 10.1007/s004390100473
104. Rodrigues, N. R., Owen, N., Talbot, K., Patel, S., Muntoni, F., Ignatius, J., et al. (1996). Gene deletions in spinal muscular atrophy. J. Med. Genet. 33, 93-96. doi: 10.1136/jmg.33.2.93
105. Rowland, L. P. (2010). Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve 41, 161-165. doi: 10.1002/mus.21565
106. Roy, N., Mahadevan, M. S., McLean, M., Shutler, G., Yaraghi, Z., Farahani, R., et al. (1995). The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80, 167-178. doi: 10.1016/0092-8674(95)90461-1
107. Russman, B. S. (2007). Spinal muscular atrophy: clinical classification and disease heterogeneity. J. Child Neurol. 22, 946-951. doi: 10.1177/0883073807305673
108. Sangaré, M., Hendrickson, B., Sango, H. A., Chen, K., Nofziger, J., Amara, A., et al. (2014). Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa. Ann. Neurol. 75, 525-532. doi: 10.1002/ana.24114
109. Scarciolla, O., Stuppia, L., De Angelis, M. V., Murru, S., Palka, C., Giuliani, R., et al. (2006). Spinal muscular atrophy genotyping by gene dosage using multiple ligation-dependent probe amplification. Neurogenetics 7, 269-276. doi: 10.1007/s10048-006-0051-3
110. Scharf, J. M., Endrizzi, M. G., Wetter, A., Huang, S., Thompson, T. G., Zerres, K., et al. (1998). Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics. Nat. Genet. 20, 83-86. doi: 10.1038/1753
111. Schmutz, J., Martin, J., Terry, A., Couronne, O., Grimwood, J., Lowry, S., et al. (2004). The DNA sequence and comparative analysis of human chromosome 5. Nature 431, 268-274. doi: 10.1038/nature02919
112. Schrank, B., Götz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., et al. (1997). Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl. Acad. Sci. U.S.A. 94, 9920-9925. doi: 10.1073/pnas.94.18.9920
113. Shan, X., Chiang, P. M., Price, D. L., and Wong, P. C. (2010). Altered distributions of gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 107, 16325-16330. doi: 10.1073/pnas.1003459107
114. Simard, L. R., Bélanger, M. C., Morissette, S., Wride, M., Prior, T. W., and Swoboda, K. J. (2007). Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA. Neurology 68, 451-456. doi: 10.1212/01.wnl.0000252934.70676.ab
115. Sreedharan, S., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672. doi: 10.1126/science.1154584
116. Stabley, D. L., Harris, A. W., Holbrook, J., Chubbs, N. J., Lozo, K. W., Crawford, T. O., et al. (2015). SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR. Mol. Genet. Genomic Med. 3, 248-257. doi: 10.1002/mgg3.141
117. Statland, J. M., Barohn, R. J., McVey, A. L., Katz, J. S., and Dimachkie, M. M. (2015). Patterns of weakness, classification of motor neuron disease and clinical diagnosis of sporadic amyotrophic lateral sclerosis. Neurol. Clin. 33, 735-748. doi: 10.1016/j.ncl.2015.07.006
118. Stratigopoulos, G., Lanzano, P., Deng, L., Guo, J., Kaufmann, P., Darras, B., et al. (2010). Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females. Arch. Neurol. 67, 1252-1256. doi: 10.1001/archneurol.2010.239
119. Su, Y. N., Hung, C. C., Li, H., Lee, C. N., Cheng, W. F., Tsao, P. N., et al. (2005). Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test. Hum. Mutat. 25, 460-467. doi: 10.1002/humu.20160
120. Su, Y. N., Hung, C. C., Lin, S. Y., Chen, F. Y., Chern, J. P. S., Tsai, C., et al. (2011). Carrier screening for spinal muscular atrophy (SMA) in 107, 611 pregnant women during the period 2005-2009: a prospective population-based cohort study. PLoS ONE 6:e17067. doi: 10.1371/journal.pone.0017067
121. Sugarman, E. A., Nagan, N., Zhu, H., Akmaev, V. R., Zhou, Z., Rohlfs, A. M., et al. (2012). Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72400 specimens. Eur. J. Hum. Genet. 20, 27-32. doi: 10.1038/ejhg.2011.134
122. Sumner, C. J., Kolb, S. J., Harmison, G. G., Jeffries, N. O., Schadt, K., Finkel, R. S., et al. (2006). SMN mRNA and protein levels in peripheral blood. Biomarkers for SMA clinical trials. Neurology 66, 1067-1073. doi: 10.1212/01.wnl.0000201929.56928.13
123. Sun, S., Ling, S. C., Qiu, J., Albuquerque, C. P., Zhou, Y., Tokunaga, S., et al. (2015). ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun. 6, 6171. doi: 10.1038/ncomms7171
124. Swinnen, B., and Robberecht, W. (2014). The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 10, 661-670. doi: 10.1038/nrneurol.2014.184
125. Swoboda, K. J., Prior, T. W., Scott, C. B., McNaught, T. P., Wride, M. C., Reyna, S. P., et al. (2005). Natural history of denervation in SMA: relation to age, SMN2 copy number and function. Ann. Neurol. 57, 704-712. doi: 10.1002/ana.20473
126. Sykes, P. J., Neoh, S. H., Brisco, M. J., Hughes, E., Condon, J., and Morley, A. A. (1992). Quantitation of targets for PCR by use of limiting dilution. Biotechniques 13, 444-449
127. Taylor, J. E., Thomas, N. H., Lewis, C. M., Abbs, S. J., Rodrigues, N. R., Davies, K. E., et al. (1998). Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Eur. J. Hum. Genet. 6, 467-474. doi: 10.1038/sj.ejhg.5200210
128. Tiziano, F. D., Bertini, E., Messina, S., Angelozzi, C., Pane, M., D'Amico, A., et al. (2007). The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study. Neuromuscul. Disord. 17, 400-403. doi: 10.1016/j.nmd.2007.02.006
129. Tiziano, F. D., Pinto, A. M., Fiori, S., Lomastro, R., Messina, S., Bruno, C., et al. (2010). SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. Eur. J. Hum. Genet. 18, 52-58. doi: 10.1038/ejhg.2009.116
130. Tsuiji, H., Iguchi, Y., Furuya, A., Kataoka, A., Hatsuta, H., Atsuta, N., et al. (2013). Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol. Med. 5, 221-234. doi: 10.1002/emmm.201202303
131. Turner, B. J., Alfazema, N., Sheean, R. K., Sleigh, J. N., Davies, K. E., Horne, M. K., et al. (2014). Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice. Neurobiol. Aging 35, 906-915. doi: 10.1016/j.neurobiolaging.2013.09.030
132. Turner, B. J., Parkinson, N. J., Davies, K. E., and Talbot, K. (2009). Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiol. Dis. 34, 511-517. doi: 10.1016/j.nbd.2009.03.005
133. van der Steege, G., Grootscholten, P. M., Cobben, J. M., Zappata, S., Scheffer, H., den Dunnen, J. T., et al. (1996). Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus at chromosome 5. Am. J. Hum. Genet. 59, 834-838
134. van der Steege, G., Grootscholten, P. M., van der Vlies, P., Draaijers, T. G., Osinga, J., Cobben, J. M., et al. (1995). PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 345, 985-986. doi: 10.1016/S0140-6736(95)90732-7
135. Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K. J., Nishimura, A. L., Sreeharan, J., et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211. doi: 10.1126/science.1165942
136. Velasco, E., Valero, C., Valero, A., Moreno, F., and Hernández-Chico, C. (1996). Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum. Mol. Genet. 5, 257-263. doi: 10.1093/hmg/5.2.257
137. Veldink, J. H., Kalmijn, S., Van der Hout, A. H., Lemmink, H. H., Groeneveld, G. J., Lummen, C., et al. (2005). SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology 65, 820-825. doi: 10.1212/01.wnl.0000174472.03292.dd
138. Veldink, J. H., van den Berg, L. H., Cobben, J. M., Stulp, R. P., De Jong, J. M. B. V., Vogels, O. J., et al. (2001). Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS. Neurology 56, 753-757. doi: 10.1212/WNL.56.6.749
139. Vezain, M., Saugier-Veber, P., Melki, J., Toutain, A., Bieth, E., Husson, M., et al. (2007). A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy. Eur. J. Hum. Genet. 15, 1054-1062. doi: 10.1038/sj.ejhg.5201885
140. Vezain, M., Saukkonen, A. M., Goina, E., Touraine, R., Manel, V., Toutain, A., et al. (2010). A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy. Hum. Mutat. 31, E1110-E1125. doi: 10.1002/humu.21173
141. Viollet, L., Bertrandy, S., Beuno Brunialti, A. L., Lefebvre, S., Burlet, P., Clermont, O., et al. (1997). cDNA isolation, expression and chromosomal localization of the mouse survival motor neuron gene (Smn). Genomics 40, 185-188. doi: 10.1006/geno.1996.4551
142. Vitte, J. M., Davoult, B., Roblot, N., Mayer, M., Joshi, V., Courageot, S., et al. (2004). Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload. Am. J. Pathol. 165, 1731-1741. doi: 10.1016/S0002-9440(10)63428-1
143. Vogelstein, B., and Kinzler, K. W. (1999). Digital PCR. Proc. Natl. Acad. Sci. U.S.A. 96, 9236-9241. doi: 10.1073/pnas.96.16.9236
144. Wan, L., Battle, D. J., Yong, J., Gubitz, A. K., Kolb, S. J., Wang, J., et al. (2005). The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy. Mol. Cell. Biol. 25, 5543-5551. doi: 10.1128/MCB.25.13.5543-5551.2005
145. Wang, C. C., Chang, J. G., Chen, Y. L., Jong, Y. J., and Wu, S. M. (2010a). Multi-exon genotyping of SMN gene in spinal muscular atrophy by universal fluorescent PCR and capillary electrophoresis. Electrophoresis 31, 2396-2404. doi: 10.1002/elps.201000124
146. Wang, C. C., Jong, Y. J., Chang, J. G., Chen, Y. L., and Wu, S. M. (2010b). Universal fluorescent multiplex PCR and capillary electrophoresis for evaluation of gene conversion between SMN1 and SMN2 in spinal muscular atrophy. Anal. Bioanal. Chem. 397, 2375-2383. doi: 10.1007/s00216-010-3761-1
147. Wang, C. C., Shih, C. J., Jong, Y. J., and Wu, S. M. (2014a). Universal fluorescent tri-probe ligation equipped with capillary electrophoresis for targeting SMN1 and SMN2 genes in diagnosis of spinal muscular atrophy. Anal. Chim. Acta 833, 40-47. doi: 10.1016/j.aca.2014.05.008
148. Wang, X. B., Cui, N. H., Gao, J. J., Qiu, X. P., and Zheng, F. (2014b). SMN1 duplications contribute to sporadic amyotrophic lateral sclerosis susceptibility: evidence from a meta-analysis. J. Neurol. Sci. 340, 63-68. doi: 10.1016/j.jns.2014.02.026
149. Wirth, B., Brichta, L., Schrank, B., Lochmüller, H., Blick, S., Baasner, A., et al. (2006). Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum. Genet. 119, 422-428. doi: 10.1007/s00439-006-0156-7
150. Wirth, B., Garbes, L., and Riessland, M. (2013). How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic applications. Curr. Opin. Genet. Dev. 23, 330-338. doi: 10.1016/j.gde.2013.03.003
151. Wirth, B., Hahnen, E., Morgan, K., DiDonato, C. J., Dadze, A., Rudnik-Schöneborn, S., et al. (1995). Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy: association of marker genotype with disease severity and candidate cDNAs. Hum. Mol. Genet. 4, 1273-1284. doi: 10.1093/hmg/4.8.1273
152. Yamazaki, T., Chen, S., Yan, B., Haertlein, T. C., Carrasco, M. A., Tapia, J. C., et al. (2012). FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2, 799-806. doi: 10.1016/j.celrep.2012.08.025
153. Yanyan, C., Yujin, Q., Jinli, B., Yuwei, J., Hong, W., and Fang, S. (2014). Correlation of PLS3 expression with disease severity in children with spinal muscular atrophy. J. Hum. Genet. 59, 24-27. doi: 10.1038/jhg.2013.111
154. Yu, Y., Chi, B., Xia, W., Gangopadhyay, J., Yamazaki, T., Winkelbauer-Hurt, M. E., et al. (2015). U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish. Nucleic Acids Res. 43, 3208-3218. doi: 10.1093/nar/gkv157
155. Zaldívar, T., Montejo, Y., Acevedo, A. M., Guerra, R., Vargas, J., Garofalo, N., et al. (2005). Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population. Neurology 65, 636-638. doi: 10.1212/01.wnl.0000172860.41953.12
156. Zhang, Z., Lotti, F., Dittmar, K., Younis, I., Wan, L., Kasim, M., et al. (2008). SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133, 585-600. doi: 10.1016/j.cell.2008.03.031
157. Zhong, Q., Bhattacharya, S., Kotsopoulos, S., Olson, J., Taly, V., Griffiths, A. D., et al. (2011). Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR. Lab Chip 11, 2167-2174. doi: 10.1039/c1lc20126c
158. Zou, T., Ilangovan, R., Yu, F., Xu, Z., and Zhou, J. (2007). SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity. Biochem. Biophys. Res. Commun. 364, 850-855. doi: 10.1016/j.bbrc.2007.10.096